documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

10 rows where docket_id = "FDA-2004-D-0045" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, last_modified, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 4

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2004-D-0045-0009 FDA Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles FDA-2004-D-0045 Waivers From the Requirement To Demonstrate Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles; Draft Revised Guidance for Industry; Availability Notice Notice of Availability 2016-09-16T04:00:00Z 2016 9 2016-09-16T04:00:00Z   2016-09-16T13:05:43Z 2016-22339 0 0 09000064822183e8
FDA-2004-D-0045-0010 FDA Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles FDA-2004-D-0045 Draft Guidance for Industry for Waivers From the Requirement to Demonstrate Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles Other Guidance 2016-09-16T04:00:00Z 2016 9 2016-09-16T04:00:00Z   2024-11-07T23:49:03Z   1 0 090000648220b184
FDA-2004-D-0045-0008 FDA Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles FDA-2004-D-0045 Draft Rev GFI Bioequivalence Waivers Other   2016-08-03T00:00:00Z 2016 8     2016-08-03T18:24:49Z   0 1 09000064821527bd
FDA-2004-D-0045-0007 FDA Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles FDA-2004-D-0045 FDA Notice Notice of Availability 2006-03-02T05:00:00Z 2006 3 2006-02-16T05:00:00Z   2016-08-05T13:58:50Z   0 0 090000648046e859
FDA-2004-D-0045-0006 FDA Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles FDA-2004-D-0045 GUIDANCE Supporting & Related Material GDL-Guidance 2006-03-02T05:00:00Z 2006 3     2008-04-12T00:34:13Z   0 0 090000648046e858
FDA-2004-D-0045-0005 FDA Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles FDA-2004-D-0045 FDA Notice 30 Day Proposed Information Collection 2005-10-25T04:00:00Z 2005 10 2005-10-21T04:00:00Z   2016-08-05T13:58:14Z   0 0 090000648046e856
FDA-2004-D-0045-0001 FDA Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles FDA-2004-D-0045 FDA Notice Notice of Availability 2004-08-03T04:00:00Z 2004 8 2004-08-02T04:00:00Z 2004-10-16T03:59:59Z 2016-08-05T13:56:43Z   0 0 090000648046e84b
FDA-2004-D-0045-0003 FDA Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles FDA-2004-D-0045 Guidance Supporting & Related Material GDL-Guidance 2004-08-03T04:00:00Z 2004 8     2008-04-12T00:34:13Z   0 0 090000648046e84d
FDA-2004-D-0045-0004 FDA Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles FDA-2004-D-0045 Guidance Supporting & Related Material GDL-Guidance 2004-08-03T04:00:00Z 2004 8     2008-04-12T00:34:13Z   0 0 090000648046e84e
FDA-2004-D-0045-0002 FDA Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles FDA-2004-D-0045 Guidance Supporting & Related Material GDL-Guidance 2004-08-03T04:00:00Z 2004 8     2008-04-12T00:34:13Z   0 0 090000648046e84c

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;